Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for TBPH

Stock Name	Theravance Biopharma Inc
Ticker	TBPH(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	KYG8807B1068
LEI	5493007VTSXP4Z6MIW52

Show aggregate TBPH holdings

News associated with TBPH

Theravance Biopharma, Inc. (NASDAQ:TBPH) Short Interest Up 25.3% in August: Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) was the target of a significant increase in short interest in August. As of August 31st, there was short interest totaling 4,460,000 shares, an increase of 25.3% from the August 15th total of 3,560,000 shares. Based on an average trading volume of 333,700 shares, the short-interest ratio […] - 2025-09-19 04:28:56
Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Average Recommendation of “Strong Buy” by Analysts: Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) has been given an average recommendation of “Strong Buy” by the five brokerages that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a buy rating and three have given a strong buy rating to the company. The average 12-month target price […] - 2025-09-17 02:58:46
Theravance Biopharma (NASDAQ:TBPH) Hits New 1-Year High Following Strong Earnings: Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) hit a new 52-week high during mid-day trading on Tuesday following a stronger than expected earnings report. The stock traded as high as $11.88 and last traded at $11.89, with a volume of 195285 shares. The stock had previously closed at $11.40. The biopharmaceutical company […] - 2025-08-13 02:58:43
Bank of New York Mellon Corp Raises Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH): Bank of New York Mellon Corp grew its stake in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 1.5% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 117,499 shares of the biopharmaceutical company’s stock after buying an additional 1,720 shares during the […] - 2025-08-01 04:26:59
Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Bought by GSA Capital Partners LLP: GSA Capital Partners LLP raised its position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 11.9% during the 1st quarter, HoldingsChannel.com reports. The firm owned 182,350 shares of the biopharmaceutical company’s stock after acquiring an additional 19,363 shares during the period. GSA Capital Partners LLP’s holdings in Theravance Biopharma were worth $1,628,000 at the […] - 2025-07-30 04:44:43
Alps Advisors Inc. Sells 3,680 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH): Alps Advisors Inc. decreased its position in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 9.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 36,079 shares of the biopharmaceutical company’s stock after selling 3,680 shares during the period. […] - 2025-07-18 04:49:01
Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Recommendation of “Moderate Buy” by Analysts: Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and one has given a strong buy recommendation […] - 2025-07-17 04:40:54
Jones Trading Initiates Coverage on Theravance Biopharma (NASDAQ:TBPH): Jones Trading initiated coverage on shares of Theravance Biopharma (NASDAQ:TBPH – Get Free Report) in a note issued to investors on Tuesday,Benzinga reports. The firm set a “buy” rating and a $24.00 price target on the biopharmaceutical company’s stock. Jones Trading’s target price suggests a potential upside of 125.99% from the stock’s current price. TBPH […] - 2025-06-19 02:18:55
Wellington Management Group LLP Acquires 7,162 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH): Wellington Management Group LLP raised its stake in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 3.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 198,491 shares of the biopharmaceutical company’s stock after buying an additional 7,162 shares during […] - 2025-06-06 06:12:49
Public Employees Retirement System of Ohio Buys New Position in Theravance Biopharma, Inc. (NASDAQ:TBPH): Public Employees Retirement System of Ohio bought a new stake in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 37,461 shares of the biopharmaceutical company’s stock, valued at approximately $353,000. Other hedge funds […] - 2025-06-05 06:14:52
Squarepoint Ops LLC Has $444,000 Position in Theravance Biopharma, Inc. (NASDAQ:TBPH): Squarepoint Ops LLC cut its position in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 52.3% in the fourth quarter, Holdings Channel reports. The institutional investor owned 47,168 shares of the biopharmaceutical company’s stock after selling 51,783 shares during the period. Squarepoint Ops LLC’s holdings in Theravance Biopharma were worth $444,000 as of […] - 2025-06-05 05:16:56
ProShare Advisors LLC Acquires New Position in Theravance Biopharma, Inc. (NASDAQ:TBPH): ProShare Advisors LLC acquired a new stake in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 12,672 shares of the biopharmaceutical company’s stock, valued at approximately $119,000. A number of other hedge funds have also added to or reduced their stakes in TBPH. Newtyn Management LLC […] - 2025-06-03 05:26:49
Ameriprise Financial Inc. Lowers Stock Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH): Ameriprise Financial Inc. reduced its stake in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 9.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 100,807 shares of the biopharmaceutical company’s stock after selling 10,825 shares during the period. Ameriprise Financial Inc.’s holdings in […] - 2025-06-02 04:19:00
Man Group plc Sells 14,851 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH): Man Group plc reduced its stake in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 59.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,328 shares of the biopharmaceutical company’s stock after selling 14,851 shares during the quarter. Man […] - 2025-05-29 05:36:58
Dimensional Fund Advisors LP Has $5.21 Million Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH): Dimensional Fund Advisors LP raised its position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 20.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 553,713 shares of the biopharmaceutical company’s stock after buying an additional 95,304 shares during the […] - 2025-05-13 06:14:52
Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Bought by Tower Research Capital LLC TRC: Tower Research Capital LLC TRC grew its position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 142.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 12,670 shares of the biopharmaceutical company’s stock after purchasing an additional 7,452 shares during the period. Tower Research Capital […] - 2025-05-09 05:22:54
Barclays PLC Raises Position in Theravance Biopharma, Inc. (NASDAQ:TBPH): Barclays PLC increased its position in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 14.0% in the 4th quarter, HoldingsChannel reports. The firm owned 74,790 shares of the biopharmaceutical company’s stock after purchasing an additional 9,210 shares during the period. Barclays PLC’s holdings in Theravance Biopharma were worth $704,000 as of its most […] - 2025-05-08 04:36:46
XTX Topco Ltd Reduces Stock Position in Theravance Biopharma, Inc. (NASDAQ:TBPH): XTX Topco Ltd lessened its holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 20.0% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 16,356 shares of the biopharmaceutical company’s stock after selling 4,083 shares during the period. XTX Topco Ltd’s holdings in Theravance […] - 2025-04-29 05:24:51
10,937 Shares in Theravance Biopharma, Inc. (NASDAQ:TBPH) Bought by Teacher Retirement System of Texas: Teacher Retirement System of Texas acquired a new position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 10,937 shares of the biopharmaceutical company’s stock, valued at approximately $103,000. Other institutional investors have […] - 2025-04-03 04:16:48
Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Rating of “Hold” by Analysts: Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) have been assigned a consensus rating of “Hold” from the five brokerages that are covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average twelve-month price […] - 2025-03-27 04:55:16
Bank of New York Mellon Corp Sells 5,282 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH): Bank of New York Mellon Corp trimmed its stake in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 4.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 115,779 shares of the biopharmaceutical company’s stock after selling 5,282 shares during the quarter. Bank of New York Mellon Corp’s holdings in Theravance Biopharma were worth $1,089,000 […] - 2025-03-25 05:14:50
Theravance Biopharma (NASDAQ:TBPH) Receives Buy Rating from HC Wainwright: HC Wainwright reaffirmed their buy rating on shares of Theravance Biopharma (NASDAQ:TBPH – Free Report) in a research report report published on Tuesday,Benzinga reports. They currently have a $15.00 price objective on the biopharmaceutical company’s stock. Theravance Biopharma Trading Up 1.2 % TBPH opened at $8.97 on Tuesday. Theravance Biopharma has a 12-month low of […] - 2025-02-26 06:49:00

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) TBPH holdings

Date	Number of TBPH Shares Held	Base Market Value of TBPH Shares	Local Market Value of TBPH Shares	Change in TBPH Shares Held	Change in TBPH Base Value	Current Price per TBPH Share Held	Previous Price per TBPH Share Held
2025-11-12 (Wednesday)	32,443	USD 576,837	USD 576,837	84	USD -21,805	USD 17.78	USD 18.5
2025-11-11 (Tuesday)	32,359	USD 598,642	USD 598,642	0	USD 110,668	USD 18.5	USD 15.08
2025-11-10 (Monday)	32,359	USD 487,974	USD 487,974	83	USD 11,903	USD 15.08	USD 14.75
2025-11-07 (Friday)	32,276	USD 476,071	USD 476,071	0	USD -3,873	USD 14.75	USD 14.87
2025-11-06 (Thursday)	32,276	USD 479,944	USD 479,944	83	USD -1,341	USD 14.87	USD 14.95
2025-11-05 (Wednesday)	32,193	USD 481,285	USD 481,285	0	USD 6,438	USD 14.95	USD 14.75
2025-11-04 (Tuesday)	32,193	USD 474,847	USD 474,847	84	USD -13,852	USD 14.75	USD 15.22
2025-11-03 (Monday)	32,109	USD 488,699	USD 488,699	0	USD 17,981	USD 15.22	USD 14.66
2025-10-31 (Friday)	32,109	USD 470,718	USD 470,718	0	USD 11,559	USD 14.66	USD 14.3
2025-10-30 (Thursday)	32,109	USD 459,159	USD 459,159	420	USD 10,126	USD 14.3	USD 14.17
2025-10-29 (Wednesday)	31,689	USD 449,033	USD 449,033	168	USD 4,587	USD 14.17	USD 14.1
2025-10-28 (Tuesday)	31,521	USD 444,446	USD 444,446	0	USD -6,304	USD 14.1	USD 14.3
2025-10-27 (Monday)	31,521	USD 450,750	USD 450,750	0	USD 630	USD 14.3	USD 14.28

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TBPH by Blackrock for IE00BDZVHG35

Show aggregate share trades of TBPH

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-12 BUY 84 17.780* 10.40
2025-11-10 BUY 83 15.080* 10.33
2025-11-06 BUY 83 14.870* 10.28
2025-11-04 BUY 84 14.750* 10.23
2025-10-30 BUY 420 14.350 14.150 14.170 USD 5,951 10.15
2025-10-29 BUY 168 14.170 14.420 14.395 USD 2,418 10.13
2025-10-22 SELL -332 14.000 14.043 14.039 USD -4,661 10.01 Loss of -1,336 on sale
2025-10-20 BUY 166 14.310 14.410 14.400 USD 2,390 9.97
2025-10-17 BUY 415 14.260 14.335 14.328 USD 5,946 9.94
2025-10-15 BUY 664 13.900 14.590 14.521 USD 9,642 9.92
2025-10-03 BUY 588 14.410 14.435 14.433 USD 8,486 9.87
2025-10-02 BUY 84 14.070 14.520 14.475 USD 1,216 9.84
2025-09-30 BUY 168 14.600 14.870 14.843 USD 2,494 9.78
2025-09-26 BUY 168 14.070 14.140 14.133 USD 2,374 9.73
2025-09-25 BUY 168 13.790 14.040 14.015 USD 2,355 9.70
2025-09-18 BUY 91 14.470 14.500 14.497 USD 1,319 9.67
2025-09-17 BUY 276 14.050 14.150 14.140 USD 3,903 9.65
2025-07-17 SELL -180 11.620 11.880 11.854 USD -2,134 9.59 Loss of -408 on sale
2025-07-11 SELL -728 11.300 11.410 11.399 USD -8,298 9.53 Loss of -1,357 on sale
2025-07-02 BUY 5,005 11.050 11.170 11.158 USD 55,846 9.49
2025-06-25 BUY 182 10.580 10.710 10.697 USD 1,947 9.45
2025-06-20 BUY 2,497 10.630 10.690 10.684 USD 26,678 9.42
2025-06-11 BUY 166 10.610 10.780 10.763 USD 1,787 9.36
2025-06-10 BUY 166 10.730 11.040 11.009 USD 1,827 9.35
2025-06-04 SELL -83 11.010 11.169 11.153 USD -926 9.30 Loss of -154 on sale
2025-04-23 BUY 83 9.450 9.510 9.504 USD 789 9.21
2025-04-10 SELL -664 8.390 8.430 8.426 USD -5,595 9.26 Profit of 551 on sale
2025-04-08 SELL -83 8.320 9.160 9.076 USD -753 9.27 Profit of 16 on sale
2025-04-07 SELL -83 8.410 8.660 8.635 USD -717 9.28 Profit of 54 on sale
2025-04-04 SELL -415 8.440 8.640 8.620 USD -3,577 9.29 Profit of 280 on sale
2025-04-01 BUY 340 9.020 9.090 9.083 USD 3,088 9.30
2025-03-31 SELL -252 8.930 9.150 9.128 USD -2,300 9.31 Profit of 45 on sale
2025-03-14 SELL -1,360 9.230 9.400 9.383 USD -12,761 9.30 Loss of -109 on sale
2025-03-07 SELL -170 9.530 9.910 9.872 USD -1,678 9.30 Loss of -98 on sale
2025-03-04 SELL -85 9.100 9.220 9.208 USD -783 9.29 Profit of 7 on sale
2025-02-25 BUY 170 8.970 9.140 9.123 USD 1,551 9.30
2025-02-19 SELL -84 9.750 9.760 9.759 USD -820 9.29 Loss of -40 on sale
2025-02-13 BUY 252 9.480 9.595 9.584 USD 2,415 9.27
2025-02-12 BUY 84 9.360 9.400 9.396 USD 789 9.27
2025-02-11 BUY 336 9.040 9.485 9.440 USD 3,172 9.27
2024-12-30 SELL -425 9.470 9.720 9.695 USD -4,120 9.13 Loss of -239 on sale
2024-11-18 SELL -1,245 9.490 9.675 9.657 USD -12,022 8.59 Loss of -1,325 on sale
2024-11-08 SELL -83 8.940 8.950 8.949 USD -743 8.55 Loss of -34 on sale
2024-10-21 SELL -85 8.660 8.780 8.768 USD -745 0.00 Loss of -745 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-12	BUY	84			17.780*		10.40
2025-11-10	BUY	83			15.080*		10.33
2025-11-06	BUY	83			14.870*		10.28
2025-11-04	BUY	84			14.750*		10.23
2025-10-30	BUY	420	14.350	14.150	14.170	USD 5,951	10.15
2025-10-29	BUY	168	14.170	14.420	14.395	USD 2,418	10.13
2025-10-22	SELL	-332	14.000	14.043	14.039	USD -4,661	10.01 Loss of -1,336 on sale
2025-10-20	BUY	166	14.310	14.410	14.400	USD 2,390	9.97
2025-10-17	BUY	415	14.260	14.335	14.328	USD 5,946	9.94
2025-10-15	BUY	664	13.900	14.590	14.521	USD 9,642	9.92
2025-10-03	BUY	588	14.410	14.435	14.433	USD 8,486	9.87
2025-10-02	BUY	84	14.070	14.520	14.475	USD 1,216	9.84
2025-09-30	BUY	168	14.600	14.870	14.843	USD 2,494	9.78
2025-09-26	BUY	168	14.070	14.140	14.133	USD 2,374	9.73
2025-09-25	BUY	168	13.790	14.040	14.015	USD 2,355	9.70
2025-09-18	BUY	91	14.470	14.500	14.497	USD 1,319	9.67
2025-09-17	BUY	276	14.050	14.150	14.140	USD 3,903	9.65
2025-07-17	SELL	-180	11.620	11.880	11.854	USD -2,134	9.59 Loss of -408 on sale
2025-07-11	SELL	-728	11.300	11.410	11.399	USD -8,298	9.53 Loss of -1,357 on sale
2025-07-02	BUY	5,005	11.050	11.170	11.158	USD 55,846	9.49
2025-06-25	BUY	182	10.580	10.710	10.697	USD 1,947	9.45
2025-06-20	BUY	2,497	10.630	10.690	10.684	USD 26,678	9.42
2025-06-11	BUY	166	10.610	10.780	10.763	USD 1,787	9.36
2025-06-10	BUY	166	10.730	11.040	11.009	USD 1,827	9.35
2025-06-04	SELL	-83	11.010	11.169	11.153	USD -926	9.30 Loss of -154 on sale
2025-04-23	BUY	83	9.450	9.510	9.504	USD 789	9.21
2025-04-10	SELL	-664	8.390	8.430	8.426	USD -5,595	9.26 Profit of 551 on sale
2025-04-08	SELL	-83	8.320	9.160	9.076	USD -753	9.27 Profit of 16 on sale
2025-04-07	SELL	-83	8.410	8.660	8.635	USD -717	9.28 Profit of 54 on sale
2025-04-04	SELL	-415	8.440	8.640	8.620	USD -3,577	9.29 Profit of 280 on sale
2025-04-01	BUY	340	9.020	9.090	9.083	USD 3,088	9.30
2025-03-31	SELL	-252	8.930	9.150	9.128	USD -2,300	9.31 Profit of 45 on sale
2025-03-14	SELL	-1,360	9.230	9.400	9.383	USD -12,761	9.30 Loss of -109 on sale
2025-03-07	SELL	-170	9.530	9.910	9.872	USD -1,678	9.30 Loss of -98 on sale
2025-03-04	SELL	-85	9.100	9.220	9.208	USD -783	9.29 Profit of 7 on sale
2025-02-25	BUY	170	8.970	9.140	9.123	USD 1,551	9.30
2025-02-19	SELL	-84	9.750	9.760	9.759	USD -820	9.29 Loss of -40 on sale
2025-02-13	BUY	252	9.480	9.595	9.584	USD 2,415	9.27
2025-02-12	BUY	84	9.360	9.400	9.396	USD 789	9.27
2025-02-11	BUY	336	9.040	9.485	9.440	USD 3,172	9.27
2024-12-30	SELL	-425	9.470	9.720	9.695	USD -4,120	9.13 Loss of -239 on sale
2024-11-18	SELL	-1,245	9.490	9.675	9.657	USD -12,022	8.59 Loss of -1,325 on sale
2024-11-08	SELL	-83	8.940	8.950	8.949	USD -743	8.55 Loss of -34 on sale
2024-10-21	SELL	-85	8.660	8.780	8.768	USD -745	0.00 Loss of -745 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TBPH

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	46,143	0	69,384	66.5%
2025-09-18	80,190	117	112,012	71.6%
2025-09-17	75,594	0	114,221	66.2%
2025-09-16	70,765	0	139,690	50.7%
2025-09-15	105,409	400	172,839	61.0%
2025-09-12	136,735	151	333,530	41.0%
2025-09-11	74,019	0	120,269	61.5%
2025-09-10	73,484	0	124,151	59.2%
2025-09-09	69,711	0	97,569	71.4%
2025-09-08	71,936	0	104,442	68.9%
2025-09-05	144,179	0	270,635	53.3%
2025-09-04	113,312	100	178,977	63.3%
2025-09-03	147,245	0	195,023	75.5%
2025-09-02	210,644	0	362,991	58.0%
2025-08-29	143,618	600	181,275	79.2%
2025-08-28	91,851	0	163,383	56.2%
2025-08-27	38,465	0	86,673	44.4%
2025-08-26	55,755	0	101,812	54.8%
2025-08-25	176,328	101,189	252,594	69.8%
2025-08-22	126,266	0	309,773	40.8%
2025-08-21	108,994	0	183,427	59.4%
2025-08-20	64,556	16,672	88,178	73.2%
2025-08-19	62,998	230	140,054	45.0%
2025-08-18	128,499	0	383,244	33.5%
2025-08-15	75,562	0	251,501	30.0%
2025-08-14	108,213	0	315,709	34.3%
2025-08-13	102,302	0	184,575	55.4%
2025-08-12	75,678	0	174,759	43.3%
2025-08-11	40,324	0	88,886	45.4%
2025-08-08	37,651	0	439,905	8.6%
2025-08-07	16,105	0	37,946	42.4%
2025-08-06	28,678	0	42,923	66.8%
2025-08-05	38,161	0	59,319	64.3%
2025-08-04	35,717	44	61,074	58.5%
2025-08-01	30,943	1,100	42,160	73.4%
2025-07-31	31,614	0	42,704	74.0%
2025-07-30	33,096	0	53,704	61.6%
2025-07-29	17,238	0	34,555	49.9%
2025-07-28	15,392	0	34,149	45.1%
2025-07-25	31,283	0	43,720	71.6%
2025-07-24	10,550	0	26,058	40.5%
2025-07-23	22,148	0	31,100	71.2%
2025-07-22	20,402	0	31,936	63.9%
2025-07-21	18,084	0	37,427	48.3%
2025-07-18	21,942	9	34,992	62.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE